Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic

Miriam Elfström(Karolinska Institutet), Joakim Dillner(Malmö University), Penelope Gray(Karolinska University Hospital)

eLife

November 17, 2023

10.7554/elife.80905

Cited by 32

Related Papers

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

|BMJ|2008|630

Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses

|Vaccine|2006|545

A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types

|Virology|2013|317

Epigenome-based cancer risk prediction: rationale, opportunities and challenges

|Nature Reviews Clinical Oncology|2018|173

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

|BMJ|2014|140